ANNALS OF ONCOLOGY, cilt.15, sa.11, ss.1622-1626, 2004 (SCI-Expanded)
Background: Current understanding of hemostatic systems enables us to better explore the enigmatic pathobiology of tamoxifen (TAM)-induced thrombotic diathesis. We have therefore aimed to assess the hemostatic changes in breast cancer patients receiving TAM on an adjuvant basis.